BindingDB logo
myBDB logout

19 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
22677529 3 Pyrrolidinobenzoic acid inhibitors of influenza virus neuraminidase: the hydrophobic side chain influences type A subtype selectivity.EBI University of Alabama at Birmingham
18242993 29 Synthesis of potent pyrrolidine influenza neuraminidase inhibitors.EBI Abbott Laboratories
11000002 10 BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design.EBI BioCryst Pharmaceuticals, Inc.
9526556 18 Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B.EBI Glaxo Wellcome Research and Development Limited
11266166 36 Sialidase inhibitors related to zanamivir. Further SAR studies of 4-amino-4H-pyran-2-carboxylic acid-6-propylamides.EBI Glaxo Wellcome Medicines Research Centre
 22 Novel inhibitors of influenza sialidases related to zanamivir. Heterocyclic replacements of the glycerol sidechainEBI TBA
 51 Novel inhibitors of influenza sialidases related to GG167 structure-activity, crystallographic and Molecular dynamics studies with 4H-pyran-2-carboxylic acid 6-carboxamidesEBI TBA
 16 Novel inhibitors of influenza sialidase related to GG167 Synthesis of 4-amino and guanidino-4H-pyran-2-carboxylic acid-6-propylamides; selective inhibitors of influenza a virus sialidaseEBI TBA
15582424 6 Design, synthesis, and structural analysis of inhibitors of influenza neuraminidase containing a 2,3-disubstituted tetrahydrofuran-5-carboxylic acid core.EBI Abbott Laboratories
11312919 22 Design, synthesis, and structural analysis of influenza neuraminidase inhibitors containing pyrrolidine cores.EBI Abbott Laboratories
10395473 19 Potent inhibition of influenza sialidase by a benzoic acid containing a 2-pyrrolidinone substituent.EBI University of Alabama at Birmingham
17253678 70 Evolution of a highly selective and potent 2-(pyridin-2-yl)-1,3,5-triazine Tie-2 kinase inhibitor.BDB Amgen
17253679 69 Alkynylpyrimidine amide derivatives as potent, selective, and orally active inhibitors of Tie-2 kinase.BDB Amgen
16621549 40 Novel 5-azaindole factor VIIa inhibitors.BDB Celera
14561087 27 Structure-activity relationships of the p38alpha MAP kinase inhibitor 1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)naph- thalen-1-yl]urea (BIRB 796).BDB Boehringer Ingelheim Pharmaceuticals Inc.
11896401 3 Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site.BDB Boehringer Ingelheim Pharmaceuticals Inc.
16303309 31 Bicyclic and tricyclic thiophenes as protein tyrosine phosphatase 1B inhibitors.BDB Wyeth Research
14516196 21 The structural basis for the selectivity of benzotriazole inhibitors of PTP1B.BDB Merck Research Laboratories
10694412 15 Thermodynamics of substrate binding to the chaperone SecB.BDB Indian Institute of Science